Advancing Evidence Generation Through HTA for Enhanced Health Outcomes: A Global Perspective

Speaker(s)

Moderator: Kanya Shah, PhD, PharmD, MBA, MS, Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago College of Pharmacy, Chicago, IL, USA
Speakers: Gihan Hamdy Elsisi, PhD, HTA office, Cairo, Egypt; Fang-Ju (Irene) Lin, PhD, Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago College of Pharmacy, Taipei City, Taiwan; Sandipan Bhattacharjee, PhD, MS, Bayer US LLC, Whippany, NJ, USA; Michael Berntgen, PharmD, PhD, Head of Scientific Evidence Generation Department, European Medicines Agency (EMA), Amsterdam, Netherlands

Presentation Documents

The ISPOR Europe 2024 Student Network Event will discuss generating evidence toward enhancing health outcomes, focusing on the translation of health technology assessment (HTA) from a global perspective. A panel of industry, regulatory, and academic experts will lead the discussion, focusing on the generation and implementation of HTA and the challenges faced in these areas. The session will showcase innovative approaches and real-world case studies that highlight successful HTA applications, explore the interface with other decision making on the technology, and examine the impact of HTA on health policy and future research. The speakers will engage in a discussion both with each other and with the audience through a question-and-answer format. This event is designed to educate not only students and early-career professionals, but also all other ISPOR members attending the conference interested in the making of HTA and its impact.

Code

124

Topic

Health Technology Assessment